-
CMP Pharma debuts Liqrev
Liqrev is indicated for the treatment of pulmonary arterial hypertension in adults to improve exercise ability and delay clinical worsening. -
Roche obtains FDA nod for Columvi
Roche’s Columvi is the first and only bispecific antibody with a fixed-duration treatment for people with relapsed or refractory diffuse large B-cell lymphoma.